0001232524-17-000073.txt : 20170308
0001232524-17-000073.hdr.sgml : 20170308
20170308173938
ACCESSION NUMBER: 0001232524-17-000073
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170306
FILED AS OF DATE: 20170308
DATE AS OF CHANGE: 20170308
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jazz Pharmaceuticals plc
CENTRAL INDEX KEY: 0001232524
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981032470
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4TH FLOOR, CONNAUGHT HOUSE
STREET 2: ONE BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
BUSINESS PHONE: 353-1-634-7800
MAIL ADDRESS:
STREET 1: 4TH FLOOR, CONNAUGHT HOUSE
STREET 2: ONE BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
FORMER COMPANY:
FORMER CONFORMED NAME: JAZZ PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20030513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Treacy Paul
CENTRAL INDEX KEY: 0001615763
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33500
FILM NUMBER: 17676129
MAIL ADDRESS:
STREET 1: C/O JAZZ PHARMACEUTICALS PLC
STREET 2: 4TH FL, CONNAUGHT HOUSE, 1 BURLINGTON RD
CITY: DUBLIN
STATE: L2
ZIP: 4
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2017-03-06
0
0001232524
Jazz Pharmaceuticals plc
JAZZ
0001615763
Treacy Paul
CONNAUGHT HOUSE, 1 BURLINGTON RD, FL. 4
DUBLIN 4
L2
IRELAND
0
1
0
0
SVP, Technical Operations
Ordinary Shares
2017-03-06
4
S
0
355
131.9745
D
18108
D
Ordinary Shares
2017-03-06
4
S
0
529
131.9749
D
17579
D
Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $131.4935 to $131.9800. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to
provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $131.5330 to $131.9800. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to
provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
By: /s/Peter A Christou, as attorney in fact For: Paul Treacy
2017-03-08